ஆளுக மருத்துவ பள்ளி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆளுக மருத்துவ பள்ளி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆளுக மருத்துவ பள்ளி Today - Breaking & Trending Today

COVID-19 vaccine trials didn't include pregnant women. So what should they do?


COVID-19 vaccine trials didn t include pregnant women. So what should they do?
FacebookTwitterEmail
1of3
Council Member Abbie Kamin goes over her paperwork with Perla Ramos CMA, and she was supposed to receive her first dose of the COVID-19 vaccine at the La Nueva Casa de Amigos clinic, in Houston, Thursday, Jan. 14, 2021, however, it was discovered that she had gotten a different vaccine within the past two weeks, forcing her to wait another week.Karen Warren, Houston Chronicle / Staff PhotographerShow MoreShow Less
2of3
Matthew Hansel with his wife, Abbie Kamin, a Houston City Councilmember, who is eight months pregnant and will soon get the COVID-19 vaccination, are shown Thursday, Jan. 21, 2021 in Houston.Melissa Phillip, Houston Chronicle / Staff photographerShow MoreShow Less ....

United States , Baylor College Of Medicine , Texas Medical Center , Rathi Asaithambi , Karen Warren , Kjersti Aaagard , Abbie Kamin , Ut Mcgovern Medical School , Council Member Abbie Kamin , Nueva Casa De Amigos Health Center , Department Of Obstetrics , Perla Ramos , Houston Chronicle , Staff Photographer , Texas Children , Baylor College , American Journal , Sonal Bhatnagar , Govern Medical School , David Lakey , Covid 19 , Texas Childrens Hospital , La Nueva Casa De Amigos Health Center , Department Of Obstetrics And Gynecology , American Journal Of Obstetrics And Gynecology , News Health ,

UTHealth in Houston and Athersys Announce Commencement of Patient Enrollment in a Phase 2 Trial Evaluating MultiStem® Cell Therapy in Trauma


News Category Global Banking & Finance Reviews
UTHealth in Houston and Athersys Announce Commencement of Patient Enrollment in a Phase 2 Trial Evaluating MultiStem® Cell Therapy in Trauma
UTHealth in Houston and Athersys Announce Commencement of Patient Enrollment in a Phase 2 Trial Evaluating MultiStem® Cell Therapy in Trauma
The University of Texas Health Science Center at Houston (UTHealth) and Athersys, Inc. (NASDAQ: ATHX) announced today that the first patient has been enrolled in a clinical study evaluating MultiStem
cell therapy for the potential early treatment of traumatic injuries and the subsequent complications that result. The MATRICS-1 (MultiStem Administration for Trauma Related Inflammation and Complications) study is being conducted at Memorial Hermann-Texas Medical Center, one of the busiest Level 1 trauma centers in the United States. ....

Memorial Hermann Hospital , United States , Texas Medical Center , University Of Texas , Karen Hunady , David Schull , Charless Cox Jr , Ivor Macleod , Robertw Mays , Uthealth Harris County Psychiatric Center , Armys Medical Research , Corporate Communications Investor Relations , Russo Partners , Multistem Administration For Trauma Related Inflammation , Kathrineg Mcgovern Medical School , Us Army , Harris Health Lyndonb Johnson Hospital , Centers For Disease Control , University Of Texas System Board Regents , Robert Cizik School Of Nursing , Ut Health Services , Memorial Hermann Foundation , Mcgovern Medical School , Technology Enterprise Consortium , Athersys Inc , Texas Health Science Center ,